About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Chemotherapy for Resectable Colorectal Liver Metastases

NCT04513457·9 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

With

Marcello Di Martino

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients older than 18 years with resectable liver metastases of histologically confirmed primary colorectal carcinoma.
Minimum follow-up of five years.

You may not be if

Patients with extrahepatic disease

The record

StatusCompleted

PhaseNo phase

Taking part967

StartedJan 2010

UpdatedMar 29, 2021

Conditions

Metastatic Colorectal Cancer Metastatic Liver Cancer

Where9

Centre Hospitalier Universitaire de Reims
Reims, France
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Hospital Clínico Universitario de Valencia
Valencia, Valencia, Spain

Clareo Health | Chemotherapy for Resectable Colorectal Liver Metastases